Cargando…

Transfusion-Transmitted Disorders 2023 with Special Attention to Bone Marrow Transplant Patients

Transfusion medicine is traditionally a strong/fundamental part of clinical practice, saving hundreds of millions of lives. However, blood-borne or transmitted infections are a well-known and feared possibility, a risk we relentlessly mitigate. Pathogens are continuously and rather quickly changing,...

Descripción completa

Detalles Bibliográficos
Autores principales: Udvardy, Miklós, Illés, Árpád, Gergely, Lajos, Pinczés, László Imre, Magyari, Ferenc, Simon, Zsófia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383292/
https://www.ncbi.nlm.nih.gov/pubmed/37513748
http://dx.doi.org/10.3390/pathogens12070901
_version_ 1785080873659400192
author Udvardy, Miklós
Illés, Árpád
Gergely, Lajos
Pinczés, László Imre
Magyari, Ferenc
Simon, Zsófia
author_facet Udvardy, Miklós
Illés, Árpád
Gergely, Lajos
Pinczés, László Imre
Magyari, Ferenc
Simon, Zsófia
author_sort Udvardy, Miklós
collection PubMed
description Transfusion medicine is traditionally a strong/fundamental part of clinical practice, saving hundreds of millions of lives. However, blood-borne or transmitted infections are a well-known and feared possibility, a risk we relentlessly mitigate. Pathogens are continuously and rather quickly changing, so during the last decade, many, sometimes exotic, new pathogens and diseases were recorded and analyzed, and some of them were proved to be transmitted with transfusions. Blood or blood component transfusions are carried out after cautious preparative screening and inactivation maneuvers, but in some instances, newly recognized agents might escape from standard screening and inactivation procedures. Here, we try to focus on some of these proven or potentially pathogenic transfusion-transmitted agents, especially in immunocompromised patients or bone marrow transplantation settings. These pathogens are sometimes new challenges for preparative procedures, and there is a need for more recent, occasionally advanced, screening and inactivation methods to recognize and eliminate the threat a new or well-known pathogen can pose. Pathogen transmission is probably even more critical in hemophiliacs or bone marrow transplant recipients, who receive plasma-derived factor preparations or blood component transfusions regularly and in large quantities, sometimes in severely immunosuppressed conditions. Moreover, it may not be emphasized enough that transfusions and plasma-derived product administrations are essential to medical care. Therefore, blood-borne transmission needs continued alertness and efforts to attain optimal benefits with minimized hazards.
format Online
Article
Text
id pubmed-10383292
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103832922023-07-30 Transfusion-Transmitted Disorders 2023 with Special Attention to Bone Marrow Transplant Patients Udvardy, Miklós Illés, Árpád Gergely, Lajos Pinczés, László Imre Magyari, Ferenc Simon, Zsófia Pathogens Review Transfusion medicine is traditionally a strong/fundamental part of clinical practice, saving hundreds of millions of lives. However, blood-borne or transmitted infections are a well-known and feared possibility, a risk we relentlessly mitigate. Pathogens are continuously and rather quickly changing, so during the last decade, many, sometimes exotic, new pathogens and diseases were recorded and analyzed, and some of them were proved to be transmitted with transfusions. Blood or blood component transfusions are carried out after cautious preparative screening and inactivation maneuvers, but in some instances, newly recognized agents might escape from standard screening and inactivation procedures. Here, we try to focus on some of these proven or potentially pathogenic transfusion-transmitted agents, especially in immunocompromised patients or bone marrow transplantation settings. These pathogens are sometimes new challenges for preparative procedures, and there is a need for more recent, occasionally advanced, screening and inactivation methods to recognize and eliminate the threat a new or well-known pathogen can pose. Pathogen transmission is probably even more critical in hemophiliacs or bone marrow transplant recipients, who receive plasma-derived factor preparations or blood component transfusions regularly and in large quantities, sometimes in severely immunosuppressed conditions. Moreover, it may not be emphasized enough that transfusions and plasma-derived product administrations are essential to medical care. Therefore, blood-borne transmission needs continued alertness and efforts to attain optimal benefits with minimized hazards. MDPI 2023-07-01 /pmc/articles/PMC10383292/ /pubmed/37513748 http://dx.doi.org/10.3390/pathogens12070901 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Udvardy, Miklós
Illés, Árpád
Gergely, Lajos
Pinczés, László Imre
Magyari, Ferenc
Simon, Zsófia
Transfusion-Transmitted Disorders 2023 with Special Attention to Bone Marrow Transplant Patients
title Transfusion-Transmitted Disorders 2023 with Special Attention to Bone Marrow Transplant Patients
title_full Transfusion-Transmitted Disorders 2023 with Special Attention to Bone Marrow Transplant Patients
title_fullStr Transfusion-Transmitted Disorders 2023 with Special Attention to Bone Marrow Transplant Patients
title_full_unstemmed Transfusion-Transmitted Disorders 2023 with Special Attention to Bone Marrow Transplant Patients
title_short Transfusion-Transmitted Disorders 2023 with Special Attention to Bone Marrow Transplant Patients
title_sort transfusion-transmitted disorders 2023 with special attention to bone marrow transplant patients
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383292/
https://www.ncbi.nlm.nih.gov/pubmed/37513748
http://dx.doi.org/10.3390/pathogens12070901
work_keys_str_mv AT udvardymiklos transfusiontransmitteddisorders2023withspecialattentiontobonemarrowtransplantpatients
AT illesarpad transfusiontransmitteddisorders2023withspecialattentiontobonemarrowtransplantpatients
AT gergelylajos transfusiontransmitteddisorders2023withspecialattentiontobonemarrowtransplantpatients
AT pinczeslaszloimre transfusiontransmitteddisorders2023withspecialattentiontobonemarrowtransplantpatients
AT magyariferenc transfusiontransmitteddisorders2023withspecialattentiontobonemarrowtransplantpatients
AT simonzsofia transfusiontransmitteddisorders2023withspecialattentiontobonemarrowtransplantpatients